Feb 6 (Reuters) - AstraZeneca AZN.L Media Call:
ASTRAZENECA CEO: CO EXPECTS HEADWINDS FROM VBP INCLUSION OF SEVERAL MEDICINES TO IMPACT GROWTH RATE OF 2025 REVENUES IN CHINA
ASTRAZENECA CEO: CO COULD NOT MAKE THE SPEKE, UK, FACILITY INVESTMENT "ECONOMICALLY VIABLE"
ASTRAZENECA CEO: ASSESSING ALTERNATIVE SITES FOR MAKING VACCINES THAT WOULD HAVE BEEN MADE AT SPEKE
ASTRAZENECA CEO: CHINA TARIFFS WILL NOT AFFECT OUR U.S. BUSINESS BECAUSE WE IMPORT NOTHING FROM CHINA TO U.S.
ASTRAZENECA CEO: IT'S POSSIBLE ILLEGAL IMPORTATION PROBE IN CHINA COULD EXTEND TO INCLUDE ENHERTU
ASTRAZENECA CEO: UK NEEDS TO CONTINUE IMPROVING THE LIFE SCIENCES INVESTMENT ENVIRONMENT
ASTRAZENECA CEO: INCREASED VBAC REBATES IN UK, INCREASING TAXES ON INDUSTRY, IS NOT ENCOURAGING
ASTRAZENECA CEO: CO APPROACHED A COUPLE OF TIMES BY CHINESE AUTHORITIES ABOUT WANG INVESTIGATION, AND CO PROVIDED INFORMATION AS NEEDED
ASTRAZENCA CEO: HAVE NOT RECEIVED NEW INFORMATION ABOUT DETAINED FORMER EXECUTIVE LEON WANG FROM CHINESE AUTHORITIES
ASTRAZENECA CEO: DON'T HAVE INFORMATION TO SHARE ON WANG, ARE NOT PERMITTED TO TALK TO HIM
ASTRAZENECA EXECUTIVE: WE WILL INTERACT WITH RFK JR ONCE CONFIRMED TO SHOW HIM BENEFITS OF OUR VACCINES
ASTRAZENECA CEO: WILL WORK WITH U.S. FDA AND HHS TO SUPPORT LIFE SCIENCES SECTOR IN U.S.
Further company coverage: AZN.L